Thursday 31 October 2024, 7pm-8.15pm
About Dr Marina Parton
Dr Marina Parton is a Medical Oncologist in Breast Cancer at The Royal Marsden. Appointed to The Royal Marsden Consultant Body in 2009, she received her oncology training at The Royal Marsden and carried out her research in neoadjuvant therapy in breast cancer as part of an MD at The Institute of Cancer Research with Professors Dowsett and Professor Smith.
Dr Parton is Lead Cancer Clinician in The Royal Marsden’s satellite chemotherapy unit, a joint venture with Kingston Hospital and Macmillan Cancer Support, and leading breast clinics at The Royal Marsden in Chelsea. She has published in breast cancer research and is principal investigator in a number of clinical trials at The Royal Marsden. She has previously been Chair of the Acute Oncology Group at The Royal Marsden, part of the Breast Pathway Group at London Cancer Alliance (LCA) and co-chair of the LCA Chemotherapy Closer to Home Group. She is involved in several national educational groups and meetings in early and secondary breast cancer and co-edited Breast Cancer Survivorship; consequences of early breast cancer treatment. Dr Parton was a member of the NICE Early Breast Guidelines update (published 2018).
What you can expect
Hormone therapy is a treatment that stops the effect of oestrogen on breast cancer cells. Dr Parton will help you understand why you’ve been prescribed hormone therapy, when it is given and the different types available. She’ll also talk through some of the side effects you may experience as well as the best way to manage them.